Guggenheim Capital LLC Cytokinetics Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 40,886 shares of CYTK stock, worth $1.98 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

40,886

Previous 41,120 0.57%

Holding current value

$1.98 Million

Previous $2.23 Million 3.1%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $11,985 - $14,077	-234 Reduced 0.57%	40,886 $2.16 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $26,227 - $41,127	-548 Reduced 1.32%	41,120 $2.23 Million
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $162,817 - $275,985	-2,554 Reduced 5.78%	41,668 $2.92 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $182,246 - $566,062	-6,780 Reduced 13.29%	44,222 $3.69 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $34,556 - $42,943	-1,173 Reduced 2.25%	51,002 $1.5 Million
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $39,763 - $49,674	1,219 Added 2.39%	52,175 $1.7 Million
Q1 2023 May 10, 2023	SELL	$33.36 - $45.71 $258,740 - $354,526	-7,756 Reduced 13.21%	50,956 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $810,905 - $1.16 Million	22,670 Added 62.9%	58,712 $2.69 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.39 Million - $1.97 Million	36,042 New	36,042 $1.75 Million
Q2 2021 Aug 13, 2021	SELL	$19.79 - $26.99 $186,223 - $253,975	-9,410 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $173,908 - $240,493	-9,365 Reduced 49.88%	9,410 $219,000
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $286,506 - $537,152	18,775 New	18,775 $390,000
Q4 2017 Feb 14, 2018	SELL	$7.25 - $15.65 $895,056 - $1.93 Million	-123,456 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $1.48 Million - $1.85 Million	123,456	123,456 $1.79 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Cytokinetics Inc Transaction History